EcoDrugPlus

Ribosomal Protein L3

Ensembl ID : ENSSTOG00000014559
Gene Symbol: RPL3
3 Cross references
279 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSSTOG00000025964
Gene Symbol: RPL34
3 Cross references
176 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSSTOG00000007901
Gene Symbol: RPL35
3 Cross references
256 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSSTOG00000008334
Gene Symbol: RPL35A
3 Cross references
442 Possible Orthologues:

Ribosomal Protein L36a Like

Ensembl ID : ENSSTOG00000033824
Gene Symbol: RPL36AL
3 Cross references
54 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSSTOG00000030968
Gene Symbol: RPL37A
3 Cross references
105 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSSTOG00000019394
Gene Symbol: RPL38
3 Cross references
193 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSSTOG00000009221
Gene Symbol: RPL4
3 Cross references
308 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSSTOG00000009409
Gene Symbol: RPL6
3 Cross references
389 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSSTOG00000004586
Gene Symbol: RPL7
3 Cross references
173 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSSTOG00000013016
Gene Symbol: RPL8
3 Cross references
218 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSSTOG00000023443
Gene Symbol: RPS11
3 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).